Published in Methods on June 01, 2000
Histone H2B as a functionally important plasminogen receptor on macrophages. Blood (2007) 1.29
The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol (2005) 1.13
Plasmodium falciparum enolase: stage-specific expression and sub-cellular localization. Malar J (2009) 1.04
Plasminogen and its receptors as regulators of cardiovascular inflammatory responses. Trends Cardiovasc Med (2010) 1.04
Bacterial plasminogen receptors utilize host plasminogen system for effective invasion and dissemination. J Biomed Biotechnol (2012) 1.01
Proteolysis of CCN1 by plasmin: functional implications. Cancer Res (2005) 0.91
Plasminogen is an important regulator in the pathogenesis of a murine model of asthma. Am J Respir Crit Care Med (2007) 0.89
Anopheles Midgut FREP1 Mediates Plasmodium Invasion. J Biol Chem (2015) 0.82
Plasminogen and fibrinogen plasma levels in coronary artery disease. Rev Bras Hematol Hemoter (2012) 0.82
Plasminogen activator inhibitor-1: a novel therapeutic target for hypertension? Circulation (2013) 0.81
Effects on human plasminogen conformation and activation rate caused by interaction with VEK-30, a peptide derived from the group A streptococcal M-like protein (PAM). Biochim Biophys Acta (2010) 0.77
Alterations in the fibrinolytic cascade post-transplant: evidence of a bimodal expression pattern. J Heart Lung Transplant (2007) 0.75
Examination of the dissociation of multichain proteins in guanidine hydrochloride by membrane osmometry. Biochemistry (1968) 2.18
Glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem (1999) 2.14
The complete amino acid sequence of bovine alpha-lactalbumin. J Biol Chem (1970) 2.03
Measurement of the binding of antifibrinolytic amino acids to various plasminogens. Arch Biochem Biophys (1972) 1.61
Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice. J Clin Invest (1998) 1.55
Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature (1997) 1.50
Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation-dependent thrombi. Am J Pathol (2001) 1.48
In utero transplantation of wild-type fetal liver cells rescues factor X-deficient mice from fatal neonatal bleeding diatheses. J Thromb Haemost (2003) 1.47
Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1. Cancer Res (2000) 1.46
Accelerated skin wound healing in plasminogen activator inhibitor-1-deficient mice. Am J Pathol (2001) 1.34
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci U S A (1997) 1.33
Activation of human plasminogen by equimolar levels of streptokinase. J Biol Chem (1977) 1.29
Human plasminogen. Methods Enzymol (1981) 1.26
Mechanism of the urokinase-catalyzed activation of human plasminogen. J Biol Chem (1976) 1.23
A characterization of native streptokinase and altered streptokinase isolated from a human plasminogen activator complex. Biochemistry (1974) 1.23
Oligosaccharide processing in the expression of human plasminogen cDNA by lepidopteran insect (Spodoptera frugiperda) cells. Biochemistry (1990) 1.22
A total fibrinogen deficiency is compatible with the development of pulmonary fibrosis in mice. Am J Pathol (2000) 1.22
A central role for plasminogen in the inflammatory response to biomaterials. J Thromb Haemost (2004) 1.22
The effect of alpha-,omega-amino acids on human plasminogen structure and activation. J Biol Chem (1978) 1.21
Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM. J Biol Chem (1998) 1.21
Blood coagulation factor X deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice. Thromb Haemost (2000) 1.20
Calcium binding properties of synthetic gamma-carboxyglutamic acid-containing marine cone snail "sleeper" peptides, conantokin-G and conantokin-T. Biochemistry (1996) 1.17
The denaturing effectiveness of guanidinium, carbamoylguanidinium, and guanylguanidinium salts. Biochemistry (1968) 1.16
Streptokinase. Methods Enzymol (1976) 1.15
Interaction of streptokinase with plasminogen. Isolation and characterization of a streptokinase degradation product. J Biol Chem (1976) 1.12
Expression of human plasminogen in Drosophila Schneider S2 cells. Protein Expr Purif (1999) 1.12
Rabbit plasminogen and plasmin isozymes. Methods Enzymol (1976) 1.11
Structure and binding determinants of the recombinant kringle-2 domain of human plasminogen to an internal peptide from a group A Streptococcal surface protein. J Mol Biol (2001) 1.10
A coagulation factor VII deficiency protects against acute inflammatory responses in mice. J Pathol (2006) 1.09
The effect of epsilon-amino caproic acid on the gross conformation of plasminogen and plasmin. Arch Biochem Biophys (1975) 1.07
Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J (1998) 1.05
The interaction of Ca2+ with human Factor IX. Arch Biochem Biophys (1981) 1.05
Effects of human fibrinogen and its cleavage products on activation of human plasminogen by streptokinase. Biochemistry (1985) 1.05
The binding-sites of rabbit muscle aldolase. Biochem Biophys Res Commun (1966) 1.04
The control of the urokinase-catalyzed activation of human glutamic acid 1-plasminogen by positive and negative effectors. J Biol Chem (1987) 1.03
The reciprocal effects of epsilon-aminohexanoic acid and chloride ion on the activation of human [Glu1]plasminogen by human urokinase. Proc Natl Acad Sci U S A (1987) 1.03
Conversion of Glu-plasminogen to Lys-plasminogen is necessary for optimal stimulation of plasminogen activation on the endothelial cell surface. J Biol Chem (2001) 1.03
Domain interactions between streptokinase and human plasminogen. Biochemistry (2001) 1.01
The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors. J Biol Chem (2001) 1.01
Purification and characterization of crotonase from Clostridium acetobutylicum. J Biol Chem (1972) 1.01
Multiplicity of rabbit plasminogen. Physical characterization. Biochemistry (1972) 1.00
Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1. Am J Pathol (2001) 1.00
Expression of three recombinant proteins using baculovirus vectors in 23 insect cell lines. Biotechnol Prog (1991) 0.99
Conformational properties of streptokinase. J Biol Chem (1989) 0.97
Structural studies on bovine lactoferrin. J Biol Chem (1970) 0.97
The presence of UDP-N-acetylglucosamine:alpha-3-D-mannoside beta 1,2-N-acetylglucosaminyltransferase I activity in Spodoptera frugiperda cells (IPLB-SF-21AE) and its enhancement as a result of baculovirus infection. J Biol Chem (1993) 0.96
Characterization of the acidic oligosaccharides assembled on the Pichia pastoris-expressed recombinant kringle 2 domain of human tissue-type plasminogen activator. Biotechnol Appl Biochem (1997) 0.95
Mapping of disulfide bridges in antifreeze proteins from overwintering larvae of the beetle Dendroides canadensis. Biochemistry (1998) 0.95
Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit. J Clin Invest (1999) 0.95
Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur. Blood (1997) 0.94
Delayed inflammatory responses to endotoxin in fibrinogen-deficient mice. J Pathol (2006) 0.93
Carbohydrate of the human plasminogen variants. II. Structure of the asparagine-linked oligosaccharide unit. J Biol Chem (1979) 0.93
Rapid formation of an anion-sensitive active site in stoichiometric complexes of streptokinase and human [Glu1]plasminogen. Proc Natl Acad Sci U S A (1986) 0.93
Stimulation of the amidase and esterase activity of activated bovine plasma protein C by monovalent cations. Biochem Biophys Res Commun (1980) 0.93
A gamma-carboxyglutamic acid (gamma) variant (gamma 6D, gamma 7D) of human activated protein C displays greatly reduced activity as an anticoagulant. Biochemistry (1990) 0.93
De novo biosynthesis of plasminogen in the anephric rat. J Appl Physiol (1975) 0.93
Structures of the asparagine-289-linked oligosaccharides assembled on recombinant human plasminogen expressed in a Mamestra brassicae cell line (IZD-MBO503). Biochemistry (1991) 0.93
Mechanism of activation of human plasminogen by the activator complex, streptokinase-plasmin. J Biol Chem (1978) 0.93
Structure and ligand binding determinants of the recombinant kringle 5 domain of human plasminogen. Biochemistry (1998) 0.92
Direct evidence for the generation of an active site in the plasminogen moiety of the streptokinase-human plasminogen activator complex. Biochem Biophys Res Commun (1974) 0.92
The generation and characterization of mice expressing a plasmin-inactivating active site mutation. J Thromb Haemost (2010) 0.92
Plasminogen activator activities of equimolar complexes of streptokinase with variant recombinant plasminogens. Biochemistry (1990) 0.91
Amino acid determinants for NMDA receptor inhibition by conantokin-T. J Neurochem (2001) 0.91
Characterization of a cDNA encoding murine coagulation factor VII. Thromb Haemost (1996) 0.90
Calcium and phospholipid binding properties of synthetic gamma-carboxyglutamic acid-containing peptides with sequence counterparts in human protein C. Biochemistry (1994) 0.90
Regulation of the streptokinase-mediated activation of human plasminogen by fibrinogen and chloride ions. J Biol Chem (1986) 0.89
Development of pulmonary fibrosis in fibrinogen-deficient mice. Ann N Y Acad Sci (2001) 0.89
Kinetic mechanism for stimulation by monovalent cations of the amidase activity of the plasma protease bovine activated protein C. Biochemistry (1985) 0.89
Structure-function relationships of the NMDA receptor antagonist conantokin peptides. Curr Drug Targets (2001) 0.89
Interaction of calcium with bovine plasma protein C. Biochemistry (1981) 0.89
O-Mannosylation of Pichia pastoris cellular and recombinant proteins. Biotechnol Appl Biochem (1998) 0.88
Contributions of thrombin targets to tissue factor-dependent metastasis in hyperthrombotic mice. J Thromb Haemost (2014) 0.88
The characterization of mice with a targeted combined deficiency of protein c and factor XI. Am J Pathol (2001) 0.88
Role of individual gamma-carboxyglutamic acid residues of activated human protein C in defining its in vitro anticoagulant activity. Blood (1992) 0.88
Carbohydrate of the human plasminogen variants. III. Structure of the O-glycosidically linked oligosaccharide unit. J Biol Chem (1979) 0.88
Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Biochem Biophys Res Commun (1998) 0.88
A kinetic evaluation of activated bovine blood coagulation factor IX toward synthetic substrates. J Biol Chem (1980) 0.87
Activation of human neo-plasminogen-Val442 by urokinase and streptokinase and a kinetic characterization of neoplasmin-Val442. J Biol Chem (1980) 0.87
Carbohydrate compositions of the rabbit plasminogen isozymes. Arch Biochem Biophys (1975) 0.87
The existence of independent domain structures in human Lys77-plasminogen. J Biol Chem (1981) 0.87
Crystal structures of the recombinant kringle 1 domain of human plasminogen in complexes with the ligands epsilon-aminocaproic acid and trans-4-(aminomethyl)cyclohexane-1-carboxylic Acid. Biochemistry (1996) 0.87
Biochemistry of human plasminogen. Semin Thromb Hemost (1984) 0.87
Sequence requirements for the N-methyl-D-aspartate receptor antagonist activity of conantokin-R. J Biol Chem (2000) 0.87
Hydrophobic amino acid residues of human anticoagulation protein C that contribute to its functional binding to phospholipid Vesicles. Biochemistry (1995) 0.86
A urokinase-type plasminogen activator deficiency diminishes the frequency of intestinal adenomas in ApcMin/+ mice. J Pathol (2007) 0.86
Calorimetric evaluation of the existence of separate domains in bovine prothrombin. Biochemistry (1981) 0.86
Roles of individual kringle domains in the functioning of positive and negative effectors of human plasminogen activation. Biochemistry (1995) 0.86
Conformational changes in conantokin-G induced upon binding of calcium and magnesium as revealed by NMR structural analysis. J Biol Chem (1998) 0.86
Interaction of streptokinase and rabbit plasminogen. Biochemistry (1973) 0.86
Contributions of individual kringle domains toward maintenance of the chloride-induced tight conformation of human glutamic acid-1 plasminogen. Biochemistry (1995) 0.86
Metabolic turnover studies on the two major forms of rat and rabbit plasminogen. J Biol Chem (1974) 0.86
Amino terminal amino acid sequences and carbohydrate of the two major forms of rabbit plasminogen. Biochem Biophys Res Commun (1973) 0.85
Amino acid residues of the kringle-4 and kringle-5 domains of human plasminogen that stabilize their interactions with omega-amino acid ligands. J Biol Chem (1994) 0.85
The binding of calcium to the activation products of bovine factor IX. J Biol Chem (1979) 0.85
NMDA-receptor antagonist requirements in conantokin-G. FEBS Lett (1998) 0.85
Appearance of plasminogen activator activity during a synchronous cycle of a rat adenocarcinoma cell line, PA-III. Exp Cell Res (1987) 0.85
Molecular weight and subunit structure of yeast enolase. Biochemistry (1970) 0.85
Purification and properties of alpha-mannosidase II from Golgi-like membranes of baculovirus-infected Spodoptera frugiperda (IPLB-SF-21AE) cells. Biochem J (1997) 0.85